Literature DB >> 11380944

Protective and susceptible HLA polymorphisms in IgA nephropathy patients with end-stage renal failure.

I I Doxiadis1, P De Lange, E De Vries, G G Persijn, F H Claas.   

Abstract

Idiopathic immunoglobulin A (IgA) nephropathy is characterised by an extreme variability in clinical course, leading to end-stage renal failure in 15-20% of adults. This subgroup of patients with IgA nephropathy is usually included in the waiting lists of organ exchange organisations. The frequency of HLA-A,B,DR antigens of this subset of IgA nephropathy patients was calculated and compared to controls. The antigens HLA-B35 and DR5 were significantly increased in the patients with relative risk values of 1.385 and 1.487, respectively. The antigens HLA-B7, B8, DR2, and DR3 were found in a significantly lower frequency in the patients as compared to the controls. The relative risk (RR) values ranged between 0.695 and 0.727. Consequently, the haplotypes HLA-A1, B8, DR3, HLA-A3, B7, DR2, HLA-A2, B7, DR2 together with HLA-A1, B15, DR4, HLA-A9, B12, DR7, and HLA-A10, B18, DR2 were found to be protective with RR values ranging from 0.309 to 0.587. The only susceptible haplotype observed was HLA-A2-B5, DR5 (RR=2.990).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11380944     DOI: 10.1034/j.1399-0039.2001.057004344.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  9 in total

1.  DQB1*060101 may contribute to susceptibility to immunoglobulin A nephropathy in southern Han Chinese.

Authors:  Wei Wang; Ming Li; Li Wang; Xueqing Yu
Journal:  Front Med       Date:  2016-12-23       Impact factor: 4.592

2.  Clinical Predictors and Prognosis of Recurrent IgA Nephropathy in the Kidney Allograft.

Authors:  Catherine R Kavanagh; Francesca Zanoni; Rita Leal; Namrata G Jain; Megan Nicole Stack; Elena-Rodica Vasilescu; Geo Serban; Carley Shaut; Jeanne Kamal; Satoru Kudose; António Martinho; Rui Alves; Dominick Santoriello; Pietro A Canetta; David Cohen; Jai Radhakrishnan; Gerald B Appel; Michael B Stokes; Glen S Markowitz; Vivette D D'Agati; Krzysztof Kiryluk; Nicole K Andeen; Ibrahim Batal
Journal:  Glomerular Dis       Date:  2021-09-24

3.  HLA polymorphism and susceptibility to end-stage renal disease in Cantonese patients awaiting kidney transplantation.

Authors:  Qiong Cao; Di Xie; Jiangmei Liu; Hongyan Zou; Yinze Zhang; Hong Zhang; Zhimei Zhang; Hao Xue; Jiyuan Zhou; Pingyan Chen
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

4.  Association between human leucocyte antigen subtypes and risk of end stage renal disease in Taiwanese: a retrospective study.

Authors:  Ciou-Sia Dai; Chen-Chung Chu; Shin-Fan Chen; Chiao-Yin Sun; Marie Lin; Chin-Chan Lee
Journal:  BMC Nephrol       Date:  2015-10-30       Impact factor: 2.388

5.  Associations between human leukocyte antigens and renal function.

Authors:  Marcus Lowe; Antony Payton; Arpana Verma; Judith Worthington; Isla Gemmell; Patrick Hamilton; William Ollier; Titus Augustine; Kay Poulton
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

6.  Relevance of HLA gene polymorphisms in Romanian patients with chronic renal insufficiency undergoing renal transplantation.

Authors:  Ion Mărunţelu; Bogdan Mihai Cristea; Secil Omer; Carmen Monica Preda; Ileana Constantinescu
Journal:  J Clin Lab Anal       Date:  2021-10-27       Impact factor: 2.352

7.  Association of end-stage renal disease with HLA phenotypes and panel reactive antibodies in patients awaiting renal transplantation in Hunan Province.

Authors:  Lu Long; Qian Sun
Journal:  J Clin Lab Anal       Date:  2022-01-26       Impact factor: 2.352

Review 8.  Systematic review of associations between HLA and renal function.

Authors:  Marcus Lowe; Steven Jervis; Antony Payton; Kay Poulton; Judith Worthington; Isla Gemmell; Arpana Verma
Journal:  Int J Immunogenet       Date:  2021-12-17       Impact factor: 2.385

9.  The genetic variants at the HLA-DRB1 gene are associated with primary IgA nephropathy in Han Chinese.

Authors:  Yang Jiyun; Li Guisen; Zhu Li; Shi Yi; Lv Jicheng; Lu Fang; Liu Xiaoqi; Ma Shi; Jing Cheng; Lin Ying; Wang Haiyan; Wang Li; Zhang Hong; Yang Zhenglin
Journal:  BMC Med Genet       Date:  2012-05-14       Impact factor: 2.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.